0001750284 2025-11-18 2025-11-18 0001750284 1 2025-11-18 2025-11-18 0001750284 2 2025-11-18 2025-11-18 0001750284 3 2025-11-18 2025-11-18 iso4217:USD pure shares S-3 S-3MEF EX-FILING FEES 333-284146 0001750284 Olema Pharmaceuticals, Inc. N/A N/A 0.0001381 0.0001381 S-3 Olema Pharmaceuticals, Inc. Equity Common Stock, par value $0.0001 per share true Other Warrants true false Unallocated (Universal) Shelf true 40000000.00 0.0001381 5524.00 40000000.00 5524.00 0.00 0.00 5524.00 The Registrant previously registered the offer and sale of certain securities, including its common stock, par value $0.0001 per share, having a proposed maximum aggregate offering price of $200,000,000 pursuant to Registration Statement on Form S-3 (File No. 333-284146), which was filed on January 6, 2025 and declared effective by the SEC on January 15, 2025 (the "Prior Registration Statement"). As of the date hereof, a balance of $200,000,000 of such securities remains unsold under the Prior Registration Statement. In accordance with Rule 462(b) under the Securities Act of 1933, as amended, and General Instruction IV(A) of Form S-3, the Registrant is hereby registering the offer and sale of an additional $40,000,000 of its shares of common stock. The additional amount of securities that is being registered for offer and sale represents no more than 20% of the maximum aggregate offering price of the remaining securities available to be sold under the Prior Registration Statement.